Author:
Luo Jie,Shi Ke,Yin Shu-ya,Tang Rui-xue,Chen Wen-jie,Huang Lin-zhen,Gan Ting-qing,Cai Zheng-wen,Chen Gang
Funder
the Promoting Project of Basic Capacity for Young and Middle-aged University Teachers in Guangxi
the Scientific Research Project of the Guangxi Education Agency
the Guangxi Zhuang Autonomous Region University Student Innovative Plan
Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.
2. Milovancev A, Stojsic V, Zaric B, Kovacevic T, Sarcev T, Perin B, Zarogoulidis K, Tsirgogianni K, Freitag L, Darwiche K, et al. EGFR-TKIs in adjuvant treatment of lung cancer: to give or not to give? Onco Targets Ther. 2015;8:2915–21.
3. Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. Targeting multidrug resistance in cancer. Nat Rev Drug Discov. 2006;5:219–34.
4. Liu J, Dong M, Sun X, Li W, Xing L, Yu J. Prognostic value of 18F-FDG PET/CT in surgical non-small cell lung cancer: a meta-analysis. PLoS One. 2016;11:e0146195.
5. Liu KJ, Ding LY, Wu HY. Bevacizumab in combination with anticancer drugs for previously treated advanced non-small cell lung cancer. Tumour Biol. 2015;36:1323–7.